Evidence map›Paper›PMID 30372447›Full record

ArticlePloS one2018

Redox proteomic insights into involvement of clathrin-mediated endocytosis in silver nanoparticles toxicity to Mytilus galloprovincialis.

Younes Bouallegui, Ridha Ben Younes, Ridha Oueslati, David Sheehan

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Nano Silver-Induced Toxicity and Associated Mechanisms.International journal of nanomedicine · 2022
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Younes BoualleguiResearch Unit of Immuno-Microbiology Environmental and Carcinogensis, Sciences Faculty of Bizerte, University of Carthage, Bizerte, Tunisia.ORCID 0000-0001-8410-0671
Ridha Ben YounesResearch Unit of Immuno-Microbiology Environmental and Carcinogensis, Sciences Faculty of Bizerte, University of Carthage, Bizerte, Tunisia.
Ridha OueslatiResearch Unit of Immuno-Microbiology Environmental and Carcinogensis, Sciences Faculty of Bizerte, University of Carthage, Bizerte, Tunisia.
David SheehanProteomic Research Group, School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland.ORCID 0000-0003-0440-2480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clathrin-mediated endocytosis is a major mode of nanoparticle (NP) internalization into cells. However, influence of internalization routes on nanoparticle toxicity is poorly understood. Here, we assess the impact of blocking clathrin-mediated endocytosis upon silver NP (AgNP) toxicity to gills and digestive glands of the mussel Mytilusgalloprovincialisusing the uptake inhibitor, amantadine. Animals were exposed for 12h to AgNP (< 50 nm) in the presence and absence of amantadine. Labeling of oxidative protein modifications, either thiol oxidation, carbonyl formation or both in two-dimensional electrophoresis separations revealed 16 differentially affected abundance spots. Amongst these, twelve hypothetical proteins were successfully identified by peptide mass fingerprinting (MALDI TOF-MS/MS). The proteins identified are involved in buffering redox status or in cytoprotection. We conclude that blockade of clathrin-mediated endocytosis protected against NP toxicity, suggesting this uptake pathway facilitates toxicity. Lysosomal degradation and autophagy are major mechanisms that might be induced to mitigate NP toxicity.

Indexed as

AmantadineAnimalsAutophagyClathrinGillsLysosomesMetal NanoparticlesMytilusOxidation-ReductionParticle SizeProteomicsSilverTandem Mass SpectrometryAmantadineClathrinSilver

Identifiers

PMID30372447
PMCPMC6205585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.